A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica
Public ClinicalTrials.gov record NCT06262607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-Design, Phase 2 Study to Assess the Efficacy and Safety of CLE-400 Topical Gel for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica
Study identification
- NCT ID
- NCT06262607
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Clexio Biosciences Ltd.
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Interventions
- CLE-400 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2024
- Primary completion
- Nov 5, 2024
- Completion
- Nov 18, 2024
- Last update posted
- Nov 17, 2025
2024
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical site 11 | Bryant | Arkansas | 72022 | — |
| Clinical Site 21 | Fremont | California | 94538 | — |
| Clinical site 01 | Coral Gables | Florida | 33134 | — |
| Clinical Site 13 | Margate | Florida | 33063 | — |
| Clinical Site 10 | North Miami Beach | Florida | 33116 | — |
| Clinical Site 02 | Indianapolis | Indiana | 46250 | — |
| Clinical Site 23 | Methuen | Massachusetts | 01844 | — |
| Clinical Site 20 | Portsmouth | New Hampshire | 03801 | — |
| Clinical Site 15 | New York | New York | 10028 | — |
| Clinical site 03 | High Point | North Carolina | 27262 | — |
| Clinical Site 09 | Dublin | Ohio | 43016 | — |
| Clinical site 16 | Houston | Texas | 77004 | — |
| Clinical Site 06 | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06262607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06262607 live on ClinicalTrials.gov.